. home.aspx

NEWS

home.aspx
   


Novavax, advancing COVID-19 shot, recruits AstraZeneca exec as its chief medical officer

June 17, 2020 / Eric Sagonowsky
SHARESHARESHARE

On the heels of some big fundraising moves and in the hunt for a COVID-19 vaccine, Novavax is adding some Big Pharma experience to its executive team.  Joining the company's leadership team as chief medical officer is Filip Dubovsky, an AstraZeneca veteran. Dubovsky joins Novavax directly from the British drugmaker, where he served as head of clinical engagement and policy, plus as chief medical officer for clinical affairs. Before that role, he oversaw a portfolio of more than two dozen malaria vaccines at the PATH Malaria Vaccine Initiative.  Dubrovsky will be tasked with overseeing development of the company's COVID-19 candidate. The company in late May kicked off a phase 1/2 study of the prospect, and it's been working through steps to scale up its manufacturing in parallel. Aside from its COVID-19 work, the company is getting ready to submit an FDA application for its flu vaccine, NanoFlu.